For colon adenocarcinoma and hepatocellular carcinoma in the ICGC/TCGA database, although statistical significance was not met, patients with an AIMP2-DX2/AIMP2 expression ratio ≥Q1 displayed worse survival outcomes (Supplementary Fig. 3). Here, AIMP2 is linked to hepatocellular carcinoma.